Every dated biotech event, with the document behind the date.The next sixty days across US-listed development-stage biotech.
Open the desk and the next sixty days are already there: what is dated, what share of the company's modelled value rides on it, and whether the cash lasts that long. Every date links to the filing or release it was read from, with the time it was last checked. The desk is rebuilt once a day.
721 dated events · 154 companies · as of 2026-09-22
See what is dated in the next sixty days.
Every US-listed development-stage biotech with a dated event, in one list. Sort it by date, filter it to the window and the confidence you care about, and every row keeps the document it came from.
A date we worked out rather than read is labelled estimated.
What each column tells you.
Company and stage, then the event and what it decides. The date, with how precise it is and whether a regulator confirmed it, the company guided to it, or we estimated it. The share of the company's modelled value the event puts at stake. Whether the filed cash reaches the date. What the company has filed about financing, which specialist funds held it at the last 13F, and what insiders did in the past ninety days. Then the research probability, and the space for yours.
There is no price on the desk, and no column here is a forecast of what a share will do.
Only 7.9% of drugs entering Phase 1 ever reach approval, and 28.9% of Phase 2 programmes reach Phase 3, the hardest gate in development◆ (source: BIO / Informa / QLS, 2011–2020, opens in a new tab). Which of those a row is describing is the whole question.
Where a public prediction market lists the same question, the row's disclosure links to it with the venue's own question and its deadline. No number comes across.
Follow a date to the document.
Click a date and the source opens: the filing, the release or the registry record it was read from, the sentence it was read from, and the time it was last checked.
Confirmed means a regulator or the company put the date in writing. Estimated means we worked it out, and the row says so.
Disagree with the odds? Put your own in.
The research gives each programme a probability of ultimate approval, labelled an estimate. Type in your own and the model value moves with it, line by line, so you can see what your view is worth before the date rather than after it.
It moves a model, not a share price. Your number is yours, and it is never published.
Free on the sample companies; Pro on every other covered company.
Save your version as a case. It is private to you, it opens to the same numbers next month or on another laptop, and when new research comes in you see what changed and choose whether to take it.
Read what the FDA already decided.
Every FDA approval and every complete response letter has its own page here. When an event turns on an application number, the row links straight to the letter or the approval it answers.
Find out what happened on the day.
When the date passes, the row resolves from the primary document: what the outcome was, where it was published, and what changed in the research because of it.
A date that passes with no announcement is a different state, and the row reads as one. Resolution follows the daily run, not the minute of the release.
“Isn't the AI just making this up?”
Fair question, and the right one to ask of anything that writes confident sentences about your money.
Estimates are labelled as estimates
A date is confirmed, company-guided or estimated, and the row says which. A probability comes from the research with its reasoning attached, or from you, and the field says which. Nothing on the desk is presented as a fact it is not.
Every number carries a date
Each event carries the source it was read from and the time it was last checked. Cash, burn and share counts keep the filing and the period they cover. A 13F is a quarter-end snapshot filed up to 45 days later, and the row says so.
If it can't be sourced, it says so
Where no primary document supports a date, there is no row. Where the cash flow needed for a runway is missing, the verdict is unknown rather than a guess. A drug the model cannot match to a programme is marked unresolved.
The terminal does not predict readouts. Every probability in it is either the research's estimate or yours.
The desk is free and needs no account: every row, every filter, every source, the filing signals and the research probability. Pro is $29 a month and adds your own probability on any covered company, saved cases, every terminal panel and export. A seven-day trial starts with your account and needs no card; when a trial or a subscription ends, the cases you saved stay readable and exportable.
Start the 7-day trial→7 days free · No card required
Start with a date you already care about.
Open the desk, find a company you have followed for a while, and check two things: whether the date matches what you thought, and whether the document behind it says what the row says.
Open the desk→Free · No account